Comparison

Cediranib European Partner

Item no. TMO-T2500-2mg
Manufacturer TargetMol
CASRN 288383-20-0
Amount 2 mg
Quantity options 100 mg 10 mM x 1 mL (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,99
Citations 1. Wedge SR, et al. Y Res. 2005 May 15; 65(10):4389-400.
Smiles O(C=1C2=C(C=C(OCCCN3CCCC3)C(OC)=C2)N=CN1)C=4C(F)=C5C(=CC4)NC(C)=C5
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias AZD2171, NSC-732208
Shipping condition Cool pack
Available
Manufacturer - Targets
FLT|||PDGFR|||VEGFR|||c-Kit|||Autophagy
KIT
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
450, 51
Target names or alias
AZD2171 , NSC-732208
Description
Cediranib (AZD2171) (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro, also inhibits Flt1/4 (IC50: 5 nM/≤3 nM), similar activity against PDGFRβ and c-Kit, selective more for VEGFR than PDGFR-α (36-fold), CSF-1R (110-fold), and Flt3 (1000-fold) in HUVEC cells.
Pathways
Angiogenesis|||Autophagy|||Tyrosine Kinase/Adaptors

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close